Confocal.nl introduces a new microscope based on RE-SCAN technology developed at the
Swammerdam Institute for Life Sciences of the University of Amsterdam. This innovative technology
converts a standard microscope into a super-resolution microscope for three-dimensional confocal
imaging: the Re-scan Confocal Microscope (RCM). RCM combines the super-resolution capability with
drastically higher sensitivity than most confocal microscopes. It is available as a highly affordable and
customized device, which is ideal for small labs with specific interests in biomedical research but also
as a working-horse at microscopy facilities. The simple technical design and open-architecture makes
the system platform- and software independent which allows plug-and-play upgrading of any standard
fluorescence microscopes.
The investment will enable Confocal.nl to strengthen its leading position in the scientific research market
and expand its business in emerging life sciences-, pharma and industrial markets. Furthermore, this
investment allows Confocal.nl to strengthen its development team and improve and expand its product
portfolio.
“During the last few years we see a shift from purchase new microscope systems to upgrading existing
microscopes within institutes to more efficiently use their funding” says Peter Drent, CEO of Confocal.nl.
Dr Erik Manders, CTO of the company and inventor of the technology, explains: “Researchers are
interested in our products not only because of the high image quality but also because it is easy-to-use,
affordable and an innovative solution. Thanks to the investment of Value Creation Capital, we will be
able to accelerate our growth and further develop the market.”
Value Creation Capital (VCC) invests in companies who are active in high-tech (TechNano Fund), cyber
security (Security of Things Fund), business software, data intelligence and IT managed services. VCC
has been founded in 2005 by serial entrepreneurs who built several fast-growing ICT and tech
companies that were subsequently sold. “Given the enormous market of microscopy industry and the
drive for higher resolutions and performance the Confocal.nl Rescan Add-on can be of tremendous
value for customers”, explains Willem van den Berg, Managing Partner of Value Creation Capital. Van
den Berg: “Confocal.nl’s modules allow for high sensitive, substantially better resolution and speed
based on rescan technology”.
UvA Ventures Holding works with the University of Amsterdam technology transfer office (IXA – UVA)
to identify exciting early stage innovations and build them into fast growing sustainable companies. Peter
Krijnsen CEO UvA Ventures adds “On behalf of UvA-IXA, UvA Ventures Holding and the shareholders
of Confocal.nl, we would like to extend a warm welcome to Value Creation Capital. We highly value their
significant experience and track record especially in the optics domain, and we feel that with this
strategic investment Confocal.nl is well positioned to accelerate their sales and marketing efforts”
For more information:
Confocal.nl B.V. Peter Drent (CEO): +31 650 543244
Value Creation Capital B.V./TechNano Fund B.V. Willem van den Berg: +31 30 225 3506